XML 43 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes

Note 18. Income Taxes

U.S. and international components of income (loss) before income taxes is as follows:

Year Ended December 31, 

(Thousands)

    

2022

    

2021

    

2020

U.S.

(51,607)

(28,573)

(147,196)

International

(3,743)

3,897

786

Loss before income taxes

$

(55,350)

$

(24,676)

$

(146,410)

Income tax expense (benefit) consisted of the following:

Year Ended December 31, 

(Thousands)

    

2022

    

2021

    

2020

Current expense (benefit)

Federal

$

$

$

State

529

179

201

Foreign

1,619

(99)

510

Total current

2,148

80

711

Deferred expense (benefit)

Federal

173

(4,617)

(15,230)

State

81

(901)

(3,003)

Foreign

(2,291)

2,070

(23)

Total deferred

(2,037)

(3,448)

(18,256)

Income tax expense (benefit)

$

111

$

(3,368)

$

(17,545)

A reconciliation of income tax expense (benefit) to the federal statutory rate is as follows:

Year Ended December 31, 

(Thousands)

    

2022

    

2021

    

2020

Income tax expense (benefit) at US statutory income tax rate

$

(11,624)

$

(5,182)

$

(30,746)

State income tax expense (benefit), net of federal benefit

(1,507)

(773)

(2,844)

Foreign rate differential

(15)

(304)

(179)

Change in fair value of warrants

6,232

Goodwill impairment

16,624

Global intangible low-taxed income ("GILTI") inclusion

1,095

22

Transaction costs

260

507

Other permanent differences

323

78

136

Step-up on C Corp conversion

(1,578)

Change in valuation allowance

7,319

632

513

Provision to return adjustments

(320)

(166)

Effect of change in foreign tax rates

(552)

1,181

Other

255

(189)

Income tax expense (benefit)

$

111

$

(3,368)

$

(17,545)

Effective tax rate

(0.20%)

13.6%

12.0%

Deferred income tax assets and liabilities were recognized on temporary differences between the financial and tax basis of existing assets and liabilities as follows:

(Thousands)

    

December 31, 2022

    

December 31, 2021

Deferred tax assets

Liabilities and reserves

$

2,300

$

3,501

Interest limitation

16,256

8,884

Net operating losses

13,483

8,850

Transaction expenses

206

79

Inventories

1,449

Stock compensation

794

Derivatives

552

Operating lease liabilities

2,430

Other

269

711

Total

37,739

22,025

Valuation allowance

(8,464)

(1,145)

Total deferred tax assets, net

$

29,275

$

20,880

Deferred tax liabilities

Property, plant and equipment

$

(13,334)

$

(10,581)

Intangible assets

(27,358)

(29,221)

Derivatives

(4,451)

Inventories

(2,035)

Right-of-use assets

(2,403)

Other

(535)

(107)

Total

(43,630)

(46,395)

Net deferred tax liability

$

(14,355)

$

(25,515)

We establish a valuation allowance to reduce deferred tax assets if, based on the weight of the available evidence, both positive and negative, for each respective tax jurisdiction, it is more likely than not that some portion or all of the deferred tax assets will not be realized. A valuation allowance related to domestic deferred tax assets of $6.9 million was recorded, of which $5.5 million was against a portion of the Company’s Section 163(j) interest limitation carryforward, and the remainder was against certain state net operating losses as of December 31, 2022. There was no such valuation allowance against domestic deferred tax assets as of December 31, 2021. A valuation allowance related to foreign deferred tax assets of $1.6 million and $1.1 million was recorded against certain foreign net operating losses as of December 31, 2022 and 2021, respectively. The amount of deferred tax assets considered realizable could be adjusted in the near term, resulting in an increase to the valuation allowance, if estimates of future taxable income during the carryforward period are reduced.

Activity in the valuation allowance is as follows:

(Thousands)

    

December 31, 2022

    

December 31, 2021

Beginning balance

$

1,145

$

513

Additions

7,319

632

Ending Balance

$

8,464

$

1,145

As of December 31, 2022, the Company had federal net operating loss carryforwards of approximately $42.9 million which do not expire. As of December 31, 2022, the Company had post-apportionment state net operating loss carryforwards of approximately $38.5 million which begin to expire in 2031. As of December 31, 2022, the Company had foreign net operating loss carryforwards of approximately $5.9 million which begin to expire in 2026.

As of December 31, 2022 and 2021, the Company’s reserve for uncertain tax positions was $0.1 million and includes potential interest and penalties, which are recorded as a component of income tax expense (benefit). The Company does not expect any significant changes to unrecognized tax benefits within the next twelve months.

As a result of the U.S. Tax Cuts and Jobs Act of 2017, or the Tax Act, our accumulated foreign earnings have been subjected to U.S. tax. Moreover, all future foreign earnings will be subject to a new territorial tax system and dividends received deduction regime in the U.S. As of December 31, 2022, undistributed earnings of certain foreign subsidiaries of approximately $8.9 million are intended to be permanently reinvested outside the U.S. Accordingly, no provision for foreign withholding tax or state income taxes associated with a distribution of these earnings has been made. Determination of the amount of the unrecognized deferred tax liability on these unremitted earnings is not practicable.

We are subject to taxation in the United States and various states and foreign jurisdictions, including the United Kingdom. As of December 31, 2022, we have no tax years under examination by the IRS, and there are currently no state or foreign income tax examinations in process. The Company is subject to United States federal income tax examinations for years after 2018 and to state and foreign income tax examinations for years after 2017.